Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro

• 主要な著者: Antonio Fernando Leis-Filho (著者), Patrícia de Faria Lainetti (著者), Priscila Emiko Kobayashi (著者), Carlos Eduardo Fonseca-Alves (著者), Renée Laufer-Amorim (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2021-06-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

HER2 is a prognostic and predictive marker widely used in breast cancer. Lapatinib is a tyrosine kinase inhibitor that works by blocking the phosphorylation of the receptor HER2. Its use is related to relatively good results in the treatment of women with HER2+ breast cancer. Thus, this study aimed...